Comparison of Interscalene Block and Suprascapular With Axillary Block

Comparison of Analgesic Effectiveness of Ultrasound Guided Interscalene Block Versus Suprascapular With Axillary Block in Shoulder Arthroplasties

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04822610

Enrollment

Registered

2021-03-30

Start date

2021-06-30

Completion date

2022-01-31

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Arthroplasty, Ultrasound Guided

Keywords

axillary block, suprascapular block

Brief summary

In this study, the investigators are going to compare the analgesia effectiveness of interscalane block and suprascapular with axillary block in shoulder arthroplasties

Detailed description

In the preoperative period, the participants will be taken to the block room. The participants will be monitored, standard sedation will be applied. The first group will be get interscalene block. The second group will be get suprascapular and axillary block. The third group patient will be get no block. Afterwards, the participants will be operated under general anesthesia. A patient-controlled analgesia device will be attached to each group of participants and their postoperative follow-up will be made.

Interventions

PROCEDUREinterscalene block

peripheral nerve block

PROCEDUREsuprascapular block + axillary block

peripheral nerve block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Masking description

open

Intervention model description

Study group - Study group- Control group

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* accepting the study protocol, * age older than 18 years and younger than 90 years, * undergoing shoulder arthroplasty surgery * the American Society of Anesthesiologist (ASA) physical status of I-II-III-IV

Exclusion criteria

* severe respiratory distress * patients with local anesthetic allergy * contralateral hemidiaphragmatic parrhesia * recurrent laryngeal nerve palsy * infection at the injection site * coagulation disorder

Design outcomes

Primary

Measure	Time frame	Description
Opioid (mg) consumption	48 hours	Opioid (mg) consumption
Measurement of postoperative pain	48 hours	VAS (visual analog scale) (0: no pain, 10: the worst pain imaginable)

Other

Measure	Time frame	Description
Postoperatif complication	postoperative period up to 3 days	yes-no
Operation time	during surgery	minutes
Beck Depression Inventory (BDI)	Will be done 3 times 1- on pre-operative hospitalization 2- in the hospital after surgery 3- in the 1st month follow-up after surgery	0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.
Patient satisfaction	postoperative period up to 3 days	5-point Likert scale: very satisfied (= 5), relatively satisfied (= 4), fairly satisfied (= 3), relatively dissatisfied (= 2) and very dissatisfied (= 1)
Hospital stay	postoperative period up to 3 days	days

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026